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Background: Although a number of studies on infectious disease trends in China exist, these studies have not
distinguished the age, period, and cohort effects simultaneously. Here, we analyze infectious disease mortality
trends among urban and rural residents in China and distinguish the age, period, and cohort effects simultaneously.
Methods: Infectious disease mortality rates (1990–2010) of urban and rural residents (5–84 years old) were obtained
from the China Health Statistical Yearbook and analyzed with an age-period-cohort (APC) model based on Intrinsic
Estimator (IE).
Results: Infectious disease mortality is relatively high at age group 5–9, reaches a minimum in adolescence (age
group 10–19), then rises with age, with the growth rate gradually slowing down from approximately age 75. From
1990 to 2010, except for a slight rise among urban residents from 2000 to 2005, the mortality of Chinese residents
experienced a substantial decline, though at a slower pace from 2005 to 2010. In contrast to the urban residents,
rural residents experienced a rapid decline in mortality during 2000 to 2005. The mortality gap between urban and
rural residents substantially narrowed during this period. Overall, later birth cohorts experienced lower infectious
disease mortality risk. From the 1906–1910 to the 1941–1945 birth cohorts, the decrease of mortality among urban
residents was significantly faster than that of subsequent birth cohorts and rural counterparts.
Conclusions: With the rapid aging of the Chinese population, the prevention and control of infectious disease in
elderly people will present greater challenges. From 1990 to 2010, the infectious disease mortality of Chinese residents
and the urban-rural disparity have experienced substantial declines. However, the re-emergence of previously prevalent
diseases and the emergence of new infectious diseases created new challenges. It is necessary to further strengthen
screening, immunization, and treatment for the elderly and for older cohorts at high risk.
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Since the founding of the People’s Republic of China,
with the improvement of living standards and the devel-
opment of medical and health services, the health of
Chinese residents has been greatly improved. Disease
patterns have also undergone tremendous change in that
chronic rather than infectious diseases have become the
leading cause of death [1–3]. Most infectious diseases
have been eliminated or controlled at a low endemic
level since the 1990s. However, upon entering the 21st* Correspondence: wpg926@whu.edu.cn
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creativecommons.org/publicdomain/zero/1.0/century, China is facing a complex scenario involving
the re-emergence of previously prevalent diseases and
the emergence of new infectious diseases [4, 5]. Entities
that continue to pose serious threats to lives and health
include HIV/AIDS, sexually transmitted diseases (e.g.,
syphilis, gonorrhea), viral hepatitis, tuberculosis, and
zoonoses (e.g., rabies, SARS, HPAI, and H1N1). Recent
infectious disease outbreaks such as SARS, HPAI, and
H1N1 remind us that any slackness in prevention and
control will probably trigger disease re-emergence [5].
Infectious diseases not only harm lives and health, but
also lead to economic losses and social instability. Con-
sidering the increasingly close contacts between Chinastributed under the terms of the Creative Commons Attribution 4.0 International
by/4.0/), which permits unrestricted use, distribution, and reproduction in any
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longer just local issues: if not quickly detected and
contained, they may transform into national and even
global pandemics [4]. Therefore, the scientific meas-
urement of trends in China’s infectious diseases is
critical.
When researching the development trend of infectious
diseases in China, special attention should be paid to the
unbalanced development between urban and rural areas.
In addition to basic living standards, there is also a con-
siderable gap in health services between them. There-
fore, the capacity for the prevention and control of
infectious diseases in these settings is different. In China,
most medical resources are concentrated in urban areas,
including the best medical institutions, facilities, and
personnel [6]. In 2012, the health expenditure per capita
was 2,969 yuan for urban residents and only 1,056 yuan
for rural residents; the former is 2.8 times that of the lat-
ter [7]. Urban and rural residents are also subject to dif-
ferent health insurance schemes and a widening income
gap. Thus, with the rapid increase of health care costs,
their medical burdens are different [1, 8–11]. The fourth
National Health Services Survey in 2008 showed that
the proportions of urban and rural residents who were
ill but did not take any therapeutic measures within the
last two weeks were 6.4 % and 12.4 % respectively and
the proportions of residents untreated for economic rea-
sons were 23.2 % and 30.6 %. The values of both indica-
tors were significantly lower among urban residents than
rural residents [12].
A number of studies on infectious disease trends in
China already exist. These studies investigated either a
variety of infectious diseases [4, 5] or focused on a spe-
cific entity. Studied disease entities include HIV/AIDS
[13–17], sexually transmitted diseases [18–20], viral
hepatitis [21–23], tuberculosis [24–26], rabies [27, 28],
and others [29–31]. They focused on comparing infec-
tious disease trends across years, and more detailed
studies cared age-specific trends. One disadvantage of
these studies is that they did not distinguish the age,
period, and cohort effects1 simultaneously. These should
be distinguished not only because of their differences,
but also because failing to do so leads to bias and makes
reliable conclusions difficult to get [32, 33], thereby af-
fecting trend attribution. Although some studies have
started using APC models to analyze infectious disease
trends outside mainland China [34–37], the model esti-
mation method used in these studies has some disadvan-
tages (see methods section). To overcome shortcomings
of former studies, we used the IE [38] to estimate the
model. Compared with other methods, this estimation
method can not only solve the problem of model identi-
fication, but also provide unbiased and relatively efficient
estimation results [39, 40].Here, we aim to analyze infectious disease mortality
trends (1990–2010) of urban and rural Chinese residents
(5–84 years old) using the APC model and to distinguish
the age, period, and cohort effects simultaneously. First,
through a descriptive analysis of age-specific mortality
rates, we will obtain a visual impression of age,
period, and birth cohort effects as well as demon-
strate the need to distinguish these three effects. We
then use the IE method to estimate the coefficients
of the age, period, and cohort variation in infectious
disease mortality.
Methods
The age-specific infectious disease mortality rates used
in this study were obtained from the China Health Stat-
istical Yearbook. Mortality rates were collected for 5-
year age groups. The APC models requires a uniform
age group interval [41], and therefore the 0, 1–4, and
above 85 age groups were not included in the analysis.
Since the mortality rates were organized in 5-year age
groups, data with a 5-year interval were used according
to the requirement of the APC model at the collective
level. In view of data availability and the APC model re-
quirements, this paper analyzes the infectious disease
mortality of Chinese urban and rural residents from
1990 to 2010. As data of year 2000 were not available,
we used the mean values of the 1999 and 2001 mortality
to represent them.
Age-specific infectious disease mortality rates are sum-
marized in the a × p table with a age groups and p time
periods. The diagonal elements of the matrix denote c (c
= a + p-1) cohorts. The oldest birth cohort observations
appear in the oldest age group and earliest years, and
the youngest appear in the youngest age group and latest
years. The data used in this study comprise 16 5-year
age groups ranging from 5–9 to 80–84 and 5 period
points with a 5-year interval from 1990 to 2010. These
yielded 20 successive 5-year birth cohorts of which the
oldest cohort was born in 1906–1910 (80–84 years old
in 1990) and the youngest cohort was born in 2001–
2005 (5–9 years old in 2010).
Methods
When analyzing infectious disease mortality, we con-
structed an APC model using the Poisson log-linear
model [42]:
log rijk
  ¼ log dijk
nijk
 
¼ μþ αi þ βj þ γk ð1Þ
In this model, rijk denotes the expected death rate of
the i-th age group in the j-th year (k-th birth cohort); dijk
denotes the expected number of deaths and is assumed
to be distributed as a Poisson variate; nijk denotes the
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cept or adjusted mean; αi denotes the effect of the i-th
age group (i = 1,……,a); βj denotes the effect of the j-th
year (j = 1,……,p); and γk denotes the effect of k-th birth
cohort (k = 1,……,c), where c = a + p-1.
For a long time, the use of Eq. (1) to construct the
APC model was hindered by the so-called “model identi-
fication problem”: Because there is a linear relationship
between age, period, and birth cohort (Birth Cohort =
Period - Age), a definite solution of the model cannot be
obtained using traditional estimation methods such as
the ordinary least squares method. Although researchers
have made various attempts to resolve the problem, such
as using a reduced model containing two of the factors
or constraining the model parameters [43], no satisfac-
tory solution was identified totally. The use of a reduced
model ignores the third effect, while constraining the pa-
rameters depends heavily on certain assumptions that
are difficult to verify [39, 40]. Here, we use IE [38] to
construct the model, which not only solves the problem
of model identification but also provides unbiased and
relatively efficient estimation results [39, 40].
Results and discussion
Descriptive analysis
To obtain a visual impression of the age, period, and
birth cohort effects of infectious disease mortality and
demonstrate the need to distinguish these three effects,
we analyzed age-specific mortality rates by period
(Fig. 1a) and cohort (Fig. 1b). Fig. 1a shows that mortal-
ity is relatively high at age 5–9 but reaches a minimum
in adolescence (age 10–19) before rising with age. How-
ever, the age pattern in Fig. 1b is quite different from
that in Fig. 1a, showing that mortality might not increase
with age but instead decline for some birth cohorts.
From 1990 to 2010, the infectious disease mortality of
urban and rural residents continuously declined, except
that the mortality of urban residents showed no appar-
ent decline between 2000 and 2005. By contrast, the
mortality of rural residents declined rapidly during 2000
to 2005. During 1990 to 2000, the mortality of rural resi-
dents was higher than that of urban residents; it was
during 2000 to 2005 that the mortality gap between
urban and rural residents shrank rapidly, with mortality
rates tending to be convergent with each other (Fig. 2).
With few exceptions, later birth cohorts showed lower
mortality.
Although comparisons of age-specific mortality are
helpful for achieving some insight into age, period, and
cohort effects, the obvious disadvantage of this approach
is that it cannot distinguish these three effects simultan-
eously. In other words, the effects will be confounded,
making reliable conclusions difficult to obtain [44]. In
Fig. 1a, for a given year, the older age group is from anearlier birth cohort, thereby confounding the age and
birth cohort effects. For a given age group, those alive in
later years also belong to later birth cohorts, thereby
confounding the period and cohort effects. Similarly, in
Fig. 1b, for a given birth cohort, the older age group was
also alive in later years, thereby confounding the age and
period effects. For a given age group, the later birth co-
horts were also alive in later years, thereby confounding
the birth cohort and period effects. In Fig. 1a, b, it is
because the age effects are confounded with the birth
cohort and period effects respectively that we observe
inconsistent age effects. In addition, although compari-
sons of age-specific mortality can provide a qualitative
impression of age, period, and birth cohort effects, it is
unable to provide a more accurate quantitative assess-
ment [45].Age, period, and birth cohort effects
To distinguish the age, period, and cohort effects simul-
taneously, this study used the APC model (IE) to analyze
infectious disease mortality trends (1990–2010) of Chin-
ese urban and rural residents (5–84 years old). Table 1
shows the estimated coefficient, standard error, and
other information. To compare the relative mortality
risk across ages, periods, and birth cohorts, we calcu-
lated the exponential value of the estimated coefficients
(exp(coef.) = ecoef.) (Table 1). Specifically, this value de-
notes the mortality relative risk (RR) of a particular age,
period, or birth cohort relative to average levels [46, 47].
To grasp age, period, and cohort effect trends more in-
tuitively, we plotted Fig. 3 based on the exponential
value.Age effects
The infectious disease mortality of Chinese residents is
relatively high at age 5–9, reaches a minimum in adoles-
cence (age group 10–19), then continues to rise with
age, with the growth rate gradually slowing down from
approximately age 75 (Fig. 3a). For example, among
rural residents, the lowest mortality occurs at age group
15–19 and the risk decreases by 64 % (1–0.241/0.660 ≈
0.635) compared with age group 5–9. Mortality RR then
persistently increases by about 17 times (4.272/0.241–
1 ≈ 16.726) until age group 80–84, with the growth rate
of mortality declining from age group 70–74. Compared
with urban residents, rural residents’ mortality rates at
age group 5–9 were much higher than the minimum
rate in adolescence, while the growth rate of mortality
after age group 70–74 declined more significantly. As
seen in Figs. 1a and 2, the mortality of children aged 5–
9 in rural areas was higher than that of urban children
before the year 2000, but this gap gradually disappeared
after 2000. Before the year 2000, the mortality of rural
(a) Age-specific mortality rates by period
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Fig. 1 Age-specific infectious disease mortality rates of Chinese urban and rural residents, 1990–2010. a Age-specific mortality rates by period.
b Age-specific mortality rates by birth cohort
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dents while an opposite trend started after 2000.
Period effects
From 1990 to 2000, the infectious disease mortality RR
of Chinese residents declined rapidly, by 44 % (1–0.812/
1.459 ≈ 0.443) in urban residents and 34 % (1–1.221/
1.844 ≈ 0.338) in rural residents (Fig. 3b). From 2000 to2005, there was a great difference in mortality trends be-
tween urban and rural residents, with urban mortality
RR increasing by 14 % (0.923/0.812–1 ≈ 0.137) and rural
mortality RR decreasing by 54 % (1–0.559/1.221 ≈
0.542). As mentioned previously, it was during this
period that the mortality gap between urban and rural
residents substantially narrowed. From 2005 to 2010, the
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Fig. 2 Age-specific infectious disease mortality rates of Chinese urban and rural residents (urban-rural disparity comparison), 1990–2010
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nearly equivalent to the value of year 2000, while the
mortality RR of rural residents decreased by 59 % (1–
0.498/1.221 ≈ 0.592) during this period.
Birth cohort effects
Among Chinese residents, later birth cohorts experi-
enced lower infectious disease mortality, with the excep-
tion of some individual cohorts (Fig. 3c). From the
1906–1910 to the 1941–1945 birth cohorts, the decrease
of mortality among urban residents was significantly fas-
ter than that of subsequent birth cohorts and rural
counterparts (the mortality RR among urban residents
declined by 68 % [1–1.087/3.353 ≈ 0.676] while that
among rural counterparts declined by 42 % [1–1.311/
2.255 ≈ 0.419]). It can be seen from Fig. 1a that the rapid
decline in the mortality of urban cohorts is partly due to
the combination of two factors: (1) the decline of urban
mortality was mainly concentrated from 1990 to 2000;
(2) the decline is more significant in middle-aged and
elderly people and becomes more obvious with age.
Thus, birth cohorts who were right at the middle-aged
and elderly stage (namely, from 1906–1910 to 1941–
1945 birth cohorts) experienced a more significant de-
cline. For the 1946–1950 to 2001–2005 birth cohorts,
the decline rates of urban mortality approached those of
rural counterparts. For birth cohorts from 1906–1910 to
2001–2005, mortality RR of urban and rural residents
decreased by 91 % (1–0.310/3.353 ≈ 0.908) and 83 % (1–
0.375/2.255 ≈ 0.834), respectively.
Conclusions
In the current study, we analyzed infectious disease mor-
tality trends (1990–2010) of urban and rural Chineseresidents (5–84 years old) using the APC model and to
estimate the age, period, and cohort effects simultan-
eously. The infectious disease mortality of Chinese resi-
dents is relatively high at age group 5–9, reaches a
minimum in adolescence (age group 10–19), and then
continues to rise with age, with the growth rate grad-
ually slowing down from approximately age 75. The
Chinese population is aging rapidly: from 2013 to 2050,
the proportion of people aged over 60 will increase rap-
idly from 13.9 to 32.8 % while the proportion of people
aged over 80 will increase from 1.6 to 6.5 % [48]. With
the rapid aging of the Chinese population, the preven-
tion and control of infectious disease in elderly people
will present a greater challenge. Due to decreased im-
munity, malnutrition, physiological changes, and many
other reasons, the elderly are not only more vulnerable
to infectious diseases, but the diseases tend to be more
severe and more difficult to treat [49–52]. Therefore, in
addition to the prevention and control of infectious dis-
eases in women and children, it is necessary to further
strengthen screening, immunization, and treatment for
the elderly at high risk.
From 1990 to 2010, the infectious disease mortality of
Chinese residents has indeed experienced a substantial
decline, except for a slight increase among urban resi-
dents from 2000 to 2005. This is largely due to the con-
tinuous improvement of living standards and the rapid
development of health services. Factors including eco-
nomic development, scientific and technological pro-
gress, as well as the government’s strong commitment
and the establishment of an infectious disease surveil-
lance and response system played an important role [4].
In contrast to the slight rise among urban residents dur-
ing 2000 to 2005, the mortality of rural residents
Table 1 APC analysis of infectious disease mortality of Chinese urban and rural residents, 1990–2010
Urban Rural
Coef. S.E. Exp (Coef.) Coef. S.E. Exp (Coef.)
Intercept −9.659*** 0.047 −9.218*** 0.043
Age
5–9 −0.999*** 0.201 0.368 −0.415** 0.141 0.660
10–14 −1.615*** 0.223 0.199 −1.296*** 0.160 0.274
15–19 −1.584*** 0.204 0.205 −1.425*** 0.150 0.241
20–24 −1.178*** 0.162 0.308 −1.055*** 0.122 0.348
25–29 −1.023*** 0.145 0.360 −1.004*** 0.115 0.366
30–34 −0.663*** 0.126 0.515 −0.701*** 0.104 0.496
35–39 −0.309** 0.107 0.734 −0.543*** 0.094 0.581
40–44 −0.082 0.094 0.921 −0.300*** 0.082 0.741
45–49 0.210** 0.080 1.234 −0.056 0.071 0.946
50–54 0.322*** 0.070 1.380 0.188** 0.061 1.207
55–59 0.545*** 0.058 1.725 0.487*** 0.050 1.627
60–64 0.822*** 0.049 2.275 0.820*** 0.043 2.270
65–69 1.090*** 0.047 2.974 1.051*** 0.043 2.861
70–74 1.359*** 0.052 3.892 1.356*** 0.049 3.881
75–79 1.532*** 0.062 4.627 1.443*** 0.059 4.233
80–84 1.573*** 0.076 4.821 1.452*** 0.073 4.272
Year
1990 0.378*** 0.037 1.459 0.612*** 0.033 1.844
1995 0.089*** 0.026 1.093 0.469*** 0.023 1.598
2000 −0.208*** 0.025 0.812 0.200*** 0.021 1.221
2005 −0.080** 0.029 0.923 −0.582*** 0.031 0.559
2010 −0.178*** 0.040 0.837 −0.698*** 0.040 0.498
Birth cohort
1906–1910 1.210*** 0.091 3.353 0.813*** 0.081 2.255
1911–1915 1.016*** 0.073 2.762 0.674*** 0.063 1.962
1916–1920 0.863*** 0.059 2.370 0.621*** 0.050 1.861
1921–1925 0.726*** 0.048 2.067 0.581*** 0.041 1.788
1926–1930 0.636*** 0.042 1.889 0.557*** 0.036 1.745
1931–1935 0.413*** 0.046 1.511 0.486*** 0.041 1.626
1936–1940 0.170** 0.058 1.185 0.308*** 0.052 1.361
1941–1945 0.083 0.071 1.087 0.271*** 0.064 1.311
1946–1950 0.183* 0.083 1.201 0.279*** 0.077 1.322
1951–1955 0.140 0.098 1.150 0.304*** 0.089 1.355
1956–1960 0.080 0.113 1.083 0.055 0.105 1.057
1961–1965 0.032 0.127 1.033 0.167 0.114 1.182
1966–1970 –0.132 0.143 0.876 0.124 0.122 1.132
1971–1975 −0.236 0.159 0.790 −0.060 0.135 0.942
1976–1980 −0.606** 0.189 0.546 −0.451** 0.151 0.637
1981–1985 −0.623*** 0.181 0.536 −0.550*** 0.137 0.577
1986–1990 −0.890*** 0.240 0.411 −0.795*** 0.171 0.452
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Table 1 APC analysis of infectious disease mortality of Chinese urban and rural residents, 1990–2010 (Continued)
1991–1995 −1.100*** 0.320 0.333 −1.183*** 0.240 0.306
1996–2000 −0.795* 0.318 0.452 −1.219*** 0.334 0.296
2001–2005 −1.170* 0.526 0.310 −0.982* 0.409 0.375
Deviance (df = 42) 6.931 8.755
AIC 4.794 5.277
BIC −177.114 −175.291
Note: * p < 0.05, ** p < 0.01, *** p < 0.001
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tality gap between urban and rural residents substan-
tially narrowed. This shows that the increased
investment in rural health services [6] following the
SARS outbreak in 2003 was indeed effective. It is espe-
cially worth noting that there was a nationwide expan-
sion of Directly Observed Treatment, Short-Course
from 2000 to 2005, which was quickly promoted after
SARS [53]. During that period, the tuberculosis mortality
rate in rural areas declined rapidly from 7.31/100,000 in(a) Age effects
(b) Period effects




















































Fig. 3 Age, period and birth cohort effects of infectious disease mortality o
effects. c Birth cohort effects2000 to 2.89/100,000 in 2005 [7]. However, the slight in-
crease in mortality among urban residents during 2000
to 2005 as well as the slowing pace of the decline in
mortality among urban and rural residents from 2005 to
2010 indicate that the re-emergence of previously preva-
lent diseases and the emergence of new infectious dis-
eases created new challenges for China’s prevention and
control of infectious disease [4, 5]. Of course, this may
be partly associated with the perfection of the infectious







f Chinese urban and rural residents, 1990–2010. a Age effects. b Period
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enced lower infectious disease mortality. This may be
largely due to the better living and health conditions of
younger cohorts and their exposure at younger ages
under these favorable circumstances [32, 34]. Mean-
while, for birth cohorts from 1906–1910 to 1941–1945,
the decrease of mortality among urban residents was sig-
nificantly faster than that of subsequent birth cohorts
and rural counterparts. This is partly because the rapid
decline in urban mortality more obviously benefited
birth cohorts who were right at the middle-aged and eld-
erly stage. Of course, it may also relate to advanced
medical development and antibiotics usage during these
birth cohorts’ early life [32]. Further studies are needed
to fully understand this difference. Given that infectious
disease mortality in older cohorts is still very high, in
addition to the prevention and control of infectious dis-
ease in younger cohorts, it is necessary to further
strengthen screening, immunization, and treatment for
older cohorts at high risk. The rapid decline of mortality
from 1906–1910 to 1941–1945 birth cohorts supports
this viewpoint, and some recent studies also indicate
that a prevention and control approach based on birth
cohort can be cost-effective [55–57]. In the United
States, the prevalence of hepatitis C is highest in the
1945–1965 birth cohorts, but many in these cohorts do
not realize they are infected; these studies suggest they
should be screened and treated.
Although we analyzed the age, period, and cohort effects
of Chinese urban and rural residents’ infectious disease
mortality, we could not further evaluate mortality trend
differences by disease-specific or gender-specific due to
data availability. This analysis is important because it can
help clarify the factors that influence infectious disease
trends and to locate people at high risk with greater accur-
acy [32]. For example, in contrast to tuberculosis and
hepatitis B, AIDS mortality is higher at middle age, has
grown steadily in recent years, and may be trending up-
ward among younger birth cohorts [35]. Also, this analysis
can help compare the results with those of existing studies
on infectious diseases in China as well as studies in other
countries. Meanwhile, further research should distinguish
the internal difference in disease mortality trends of urban
and rural residents. Since the reform and opening-up pol-
icy2, the disparity within urban and rural areas continues
to expand, and regional disparity is particularly worrisome
[58]. This disparity makes a big difference in the ability of
various regions to cope with disease, and is evident in the
proportions of people who were ill but did not take any
therapeutic measures within the last two weeks. In 2008,
the proportion in big cities was 19.1 % while that in small
cities was as high as 27.3 %; the proportion in first class
rural areas was 28.5 % and that in fourth class rural areas
was 35.5 % [12]. For residents who are from Central andWestern regions, especially the rural areas of these re-
gions, poverty is still an important factor threatening their
health; conversely, diseases are also an important reason
for their return to poverty [8].Endnotes
1Age effects refer to the risk differences between dif-
ferent age groups. As people age, changes in physio-
logical status, social roles and life experiences will bring
these differences. Period effects refer to the risk differ-
ences between different years. These differences reflect
the changes of environment or the impact of historical
events. Birth cohort effects refer to the risk between dif-
ferent birth cohorts. Different birth cohorts go through
stages of life in different years and therefore different life
trajectories bring them unique effects [32, 33].
2It refers to the program of reforms called “socialism
with Chinese characteristics” since 1978 and involves
economic, political, cultural and other domains. In the
economic domains, China has gradually established the
socialist market economic system, and actively tried to
attract foreign investment and develop foreign trade. In
this process, the Chinese economy has achieved great
achievements, but the gap between rich and poor has
also been widening rapidly.
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